2019
DOI: 10.1097/qad.0000000000002302
|View full text |Cite
|
Sign up to set email alerts
|

Growth curve modelling to determine distinct BMI trajectory groups in HIV-positive adults on antiretroviral therapy in South Africa

Abstract: Objective: Obesity is a major long-term concern in HIV-positive patients due to the pathogenic link between obesity and non-communicable chronic diseases (NCD). We aim to characterize changes in body mass index (BMI) over time on antiretroviral therapy (ART) and investigate the association between weight gain and survival in South Africa.Design & Methods: Prospective cohort study among HIV-positive adults on first-line ART between April 2004-2015 in Johannesburg, South Africa. We used latent-class growth model… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
8
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 50 publications
2
8
1
Order By: Relevance
“…The gain in CD4+ T cells increased with baseline BMI, and with a longer follow-up, the gain in CD4+ T cells in obese patients changed significantly [24,25]. CD4+ T cells continued to increase with the length of follow-up, especially in the first year, when the rate of CD4+ T-cell growth was most significant, a finding that is consistent with other studies [26,27]. The gain level of CD4+ T cells in overweight patients was not significantly different from that in normal BMI patients in the first year, while the gain level of CD4 + T cells in obese patients was higher than that in normal BMI patients in our study.…”
Section: Plos Onesupporting
confidence: 89%
“…The gain in CD4+ T cells increased with baseline BMI, and with a longer follow-up, the gain in CD4+ T cells in obese patients changed significantly [24,25]. CD4+ T cells continued to increase with the length of follow-up, especially in the first year, when the rate of CD4+ T-cell growth was most significant, a finding that is consistent with other studies [26,27]. The gain level of CD4+ T cells in overweight patients was not significantly different from that in normal BMI patients in the first year, while the gain level of CD4 + T cells in obese patients was higher than that in normal BMI patients in our study.…”
Section: Plos Onesupporting
confidence: 89%
“…As for BMI, we found statistically significant differences in proportions of overweight and obesity (62.5% in controls vs 30.6%). Cumulative evidence suggests a tendency of increased BMI in PLWHIV, which seems abrupt in the first year of ART [ 30 ] and more apparent in patients using protease inhibitors. [ 31 ] Nonetheless, the proportion of obesity in PLWHIV was comparable to what has been reported previously (ie, about one-third of PLWHIV).…”
Section: Discussionmentioning
confidence: 99%
“…[ 31 ] Nonetheless, the proportion of obesity in PLWHIV was comparable to what has been reported previously (ie, about one-third of PLWHIV). [ 30 , 31 ]…”
Section: Discussionmentioning
confidence: 99%
“…It is marked the decreasing number of TLC and CD4 among people living with HIV (PLHIV) then followed by symptoms like persistent diarrhoea, drastic weight loss without knowing the reason, fever and muscle ache (Pitri, 2013). As a result, PLHIV will experience nutritional status disorders, which is marked by a low BMI score (Pusdiklat, 2014;Brennan, 2019). Excessive catabolism occurs followed by lower levels of albumin in the blood.…”
Section: Introductionmentioning
confidence: 99%